Sodium Sulfacetamide And Sulfur Lotion
NDC Package 44523-607-01
Package Information
Sodium Sulfacetamide And Sulfur (sulfacetamide sodium, sulfur) lotions is a medication indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. This formulation utilizes a lotion delivery system. Marketed by Biocomp Pharma, Inc., this product is identified by NDC 44523-607.
Identification & Billing
- RxCUI: 1005856 - sulfacetamide sodium 10 % / sulfur 5 % Topical Lotion
- RxCUI: 1005856 - sulfacetamide sodium 100 MG/ML / sulfur 50 MG/ML Topical Lotion
- RxCUI: 1005856 - sulfacetamide sodium 10 % / sulfur 5 % Topical Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 44523 - Biocomp Pharma, Inc.
- 44523-607 - Sodium Sulfacetamide And Sulfur
- 44523-607-01 - 30 g in 1 BOTTLE, PLASTIC
- 44523-607 - Sodium Sulfacetamide And Sulfur
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (44523-607). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 44523-607-01 identifies a specific commercial package of 30 g in 1 bottle, plastic of Sodium Sulfacetamide And Sulfur, a human prescription drug labeled by Biocomp Pharma, Inc.. This lotion is formulated for topical use and contains sulfacetamide sodium; sulfur as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Biocomp Pharma, Inc. on June 04, 2011. The current certification is valid through December 31, 2027.
How is this Biocomp Pharma, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 44523060701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.